INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $37,000 | -90.5% | 27,252 | -89.1% | 0.00% | – |
Q3 2016 | $389,000 | -6.9% | 249,597 | -20.6% | 0.00% | – |
Q2 2016 | $418,000 | -73.0% | 314,181 | +7.1% | 0.00% | -100.0% |
Q1 2016 | $1,546,000 | -10.9% | 293,447 | +32.8% | 0.00% | 0.0% |
Q4 2015 | $1,735,000 | -17.9% | 220,981 | -11.5% | 0.00% | -33.3% |
Q3 2015 | $2,112,000 | -32.9% | 249,792 | -13.1% | 0.00% | 0.0% |
Q2 2015 | $3,149,000 | -0.3% | 287,603 | +27.3% | 0.00% | 0.0% |
Q1 2015 | $3,158,000 | +4.1% | 225,839 | +25.8% | 0.00% | 0.0% |
Q4 2014 | $3,033,000 | +43.5% | 179,530 | +14.0% | 0.00% | +50.0% |
Q3 2014 | $2,113,000 | -54.2% | 157,438 | -56.5% | 0.00% | -50.0% |
Q2 2014 | $4,611,000 | -20.4% | 361,958 | -25.7% | 0.00% | -20.0% |
Q1 2014 | $5,791,000 | +10.0% | 487,157 | +27.8% | 0.01% | +25.0% |
Q4 2013 | $5,265,000 | +25.7% | 381,251 | +58.6% | 0.00% | 0.0% |
Q3 2013 | $4,189,000 | +22.5% | 240,326 | +13.8% | 0.00% | +33.3% |
Q2 2013 | $3,420,000 | +158.9% | 211,171 | +675.2% | 0.00% | +200.0% |
Q1 2013 | $1,321,000 | – | 27,241 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |